VAH Versus VA for Salvage Therapy of R/R-AML

Clinical trial NCT05457361 · UNKNOWN

Trial details

NCT number: NCT05457361
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Venetoclax Combined With Azacitidine Plus Homoharringtonine Venetoclax Combined With Azacitidine

Start date: 2022-03-01
Primary completion: 2022-12-31
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.